74 related articles for article (PubMed ID: 11815730)
41. Multifocal C-cell Hyperplasia and Marked Hypercalcitoninemia in a Diabetic Patient Treated With Glucagon-Like Peptide-1 Agonist With Concurrent Multinodular Goiter and Hyperparathyroidism.
Zou S; McDow AD; Saeed Z; Hou T
Cureus; 2023 Jan; 15(1):e33384. PubMed ID: 36751230
[TBL] [Abstract][Full Text] [Related]
42. [Analysis of mutations in the RET proto-oncogene in patients with medullary thyroid tumor].
Amosenko FA; Brzhezovskiĭ VZh; Liubchenko LN; Shabanov MA; Kozlova VM; Vanushko VE; Kazubskaia TP; Gar'kavtseva RF; Kalinin VN
Genetika; 2003 Jun; 39(6):847-54. PubMed ID: 12884527
[TBL] [Abstract][Full Text] [Related]
43. The RET E616Q Variant is a Gain of Function Mutation Present in a Family with Features of Multiple Endocrine Neoplasia 2A.
Grey W; Hulse R; Yakovleva A; Genkova D; Whitelaw B; Solomon E; Diaz-Cano SJ; Izatt L
Endocr Pathol; 2017 Mar; 28(1):41-48. PubMed ID: 27704398
[TBL] [Abstract][Full Text] [Related]
44. Twenty years of lesson learning: how does the RET genetic screening test impact the clinical management of medullary thyroid cancer?
Romei C; Tacito A; Molinaro E; Agate L; Bottici V; Viola D; Matrone A; Biagini A; Casella F; Ciampi R; Materazzi G; Miccoli P; Torregrossa L; Ugolini C; Basolo F; Vitti P; Elisei R
Clin Endocrinol (Oxf); 2015 Jun; 82(6):892-9. PubMed ID: 25440022
[TBL] [Abstract][Full Text] [Related]
45. What Is the Malignancy Risk in Neurofibromatosis Type 1?
Evans DG
J Clin Oncol; 2016 Jun; 34(17):1967-9. PubMed ID: 27001592
[No Abstract] [Full Text] [Related]
46. Not Only
Castroneves LA; Mangone FRR; Lerario AM; da Cunha Mercante AM; Batista RL; Barros LRC; Ferreira CV; Farias EC; Vanderlei FAB; Maia AL; Nagai MA; Jorge AAL; Hoff AO
J Endocr Soc; 2024 Apr; 8(6):bvae059. PubMed ID: 38655100
[TBL] [Abstract][Full Text] [Related]
47. Integrated proteogenomic characterization of medullary thyroid carcinoma.
Shi X; Sun Y; Shen C; Zhang Y; Shi R; Zhang F; Liao T; Lv G; Zhu Z; Jiao L; Li P; Xu T; Qu N; Huang N; Hu J; Zhang T; Gu Y; Qin G; Guan H; Pu W; Li Y; Geng X; Zhang Y; Chen T; Huang S; Zhang Z; Ge S; Wang W; Xu W; Yu P; Lu Z; Wang Y; Guo L; Wang Y; Guo T; Ji Q; Wei W
Cell Discov; 2022 Nov; 8(1):120. PubMed ID: 36344509
[TBL] [Abstract][Full Text] [Related]
48. Vandetanib in a Child Affected by Neurofibromatosis Type 1 and Medullary Thyroid Carcinoma with Both
Demir Gündoğan B; Sağcan F; Tuğ Bozdoğan S; Balcı Y; Tuncel Daloğlu F; Çağlar Çıtak E
J Clin Res Pediatr Endocrinol; 2021 Aug; 13(3):342-346. PubMed ID: 32702947
[TBL] [Abstract][Full Text] [Related]
49. [Thyroid C cells and their pathology: Part 1: normal C cells, - C cell hyperplasia, - precursor of familial medullary thyroid carcinoma].
Ting S; Synoracki S; Schmid KW
Pathologe; 2015 May; 36(3):246-53. PubMed ID: 25898937
[TBL] [Abstract][Full Text] [Related]
50. [Non-neoplastic hypercalcitoninemia. Pathological anatomy].
Saint-André JP; Guyétant S
Ann Endocrinol (Paris); 1996; 57(1):23-6. PubMed ID: 8734285
[TBL] [Abstract][Full Text] [Related]
51. Thyroid C-cell hyperplasia in an adolescent with neurofibromatosis type 1.
Segni M; Massa R; Bonifacio V; Tartaglia F; Pucarelli I; Marzullo A; Pasquino AM
Horm Res; 2001; 56(1-2):63-6. PubMed ID: 11815730
[TBL] [Abstract][Full Text] [Related]
52. Patient affected by neurofibromatosis type 1 and thyroid C-cell hyperplasia harboring pathogenic germ-line mutations in both NF1 and RET genes.
Ercolino T; Lai R; Giachè V; Melchionda S; Carella M; Delitala A; Mannelli M; Fanciulli G
Gene; 2014 Feb; 536(2):332-5. PubMed ID: 24361808
[TBL] [Abstract][Full Text] [Related]
53. C-cell hyperplasia and medullary thyroid carcinoma: clinicopathological and genetic correlations in 66 consecutive patients.
Guyétant S; Josselin N; Savagner F; Rohmer V; Michalak S; Saint-André JP
Mod Pathol; 2003 Aug; 16(8):756-63. PubMed ID: 12920219
[TBL] [Abstract][Full Text] [Related]
54. Absence of RET gene point mutations in sporadic thyroid C-cell hyperplasia.
Saggiorato E; Rapa I; Garino F; Bussolati G; Orlandi F; Papotti M; Volante M
J Mol Diagn; 2007 Apr; 9(2):214-9. PubMed ID: 17384213
[TBL] [Abstract][Full Text] [Related]
55. Immunohistochemistry of medullary thyroid carcinoma and C-cell hyperplasia by an affinity-purified anti-human calcitonin antiserum.
Hayashida CY; Alves VA; Kanamura CT; Ezabella MC; Abelin NM; Nicolau W; Bisi H; Toledo SP
Cancer; 1993 Aug; 72(4):1356-63. PubMed ID: 8339225
[TBL] [Abstract][Full Text] [Related]
56. Predictive value of pentagastrin test for preoperative differential diagnosis between C-cell hyperplasia and medullary thyroid carcinoma in patients with moderately elevated basal calcitonin levels.
Milone F; Ramundo V; Chiofalo MG; Severino R; Paciolla I; Pezzullo L; Lombardi G; Colao A; Faggiano A
Clin Endocrinol (Oxf); 2010 Jul; 73(1):85-8. PubMed ID: 20039894
[TBL] [Abstract][Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]